Comparative Risk of Venous Thromboembolism with Tofacitinib versus Tumour Necrosis Factor Inhibitor: A Cohort study of Rheumatoid Arthritis Patients
Desai RJ, et al. Arthritis Rheumatol. 2019 June;71(6):892-900.
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Desai RJ, et al. Arthritis Rheumatol. 2019 June;71(6):892-900.
Ann Rheum Dis. 2018 Jul;77(7):988-995. DOI 10.1136/annrheumdis-2017-212461
ADV Ther 2018; 35(10):1525–63 DOI: 10.1007/s12325-018-0757-2
Ann Rheum Dis 2018; 77:1268–1275 DOI: 10.1093/rheumatology/key121
Rheumatology 2018;57:1423–1431 DOI: 10.1093/rheumatology/key121
Arthritis Care Res (Hoboken) 2019 Jan;71(1):71-79. DOI: 10.1002/acr.23585
Rheumatol Ther 2018 Jun; 5(1):283–91
J Rheumatol 2018 Apr; 45(4):456-464
J Rheumatol 2018 Feb; 45(2):177-87